NCT06518382View on ClinicalTrials.gov

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

Not yet recruitingOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

August 31, 2027

Conditions

HER2-positive Breast Cancer

Trial Locations (1)

20132

IRCCS San Raffaele Hospital, Milan

All Listed Sponsors

lead

Giampaolo Bianchini

OTHER